These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 19286376

  • 1. Fluorinated non-imidazole histamine H3 receptor antagonists.
    Isensee K, Amon M, Garlapati A, Ligneau X, Camelin JC, Capet M, Schwartz JC, Stark H.
    Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2172-5. PubMed ID: 19286376
    [Abstract] [Full Text] [Related]

  • 2. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
    Liedtke S, Flau K, Kathmann M, Schlicker E, Stark H, Meier G, Schunack W.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan 15; 367(1):43-50. PubMed ID: 12616340
    [Abstract] [Full Text] [Related]

  • 3. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
    Walter M, von Coburg Y, Isensee K, Sander K, Ligneau X, Camelin JC, Schwartz JC, Stark H.
    Bioorg Med Chem Lett; 2010 Oct 01; 20(19):5879-82. PubMed ID: 20728354
    [Abstract] [Full Text] [Related]

  • 4. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
    Lim HD, Istyastono EP, van de Stolpe A, Romeo G, Gobbi S, Schepers M, Lahaye R, Menge WM, Zuiderveld OP, Jongejan A, Smits RA, Bakker RA, Haaksma EE, Leurs R, de Esch IJ.
    Bioorg Med Chem; 2009 Jun 01; 17(11):3987-94. PubMed ID: 19414267
    [Abstract] [Full Text] [Related]

  • 5. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D, Kuder K, Ligneau X, Camelin JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2009 Apr 15; 17(8):3037-42. PubMed ID: 19329325
    [Abstract] [Full Text] [Related]

  • 6. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
    Célanire S, Wijtmans M, Christophe B, Collart P, de Esch I, Dassesse D, Delaunoy C, Denonne F, Durieu V, Gelens E, Gillard M, Lallemand B, Lamberty Y, Lebon F, Nicolas JM, Quéré L, Snip E, Vanbellinghen A, Van Houtvin N, Verbois V, Timmerman H, Talaga P, Leurs R, Provins L.
    ChemMedChem; 2009 Jul 15; 4(7):1063-8. PubMed ID: 19405064
    [Abstract] [Full Text] [Related]

  • 7. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Bioorg Med Chem; 2004 May 15; 12(10):2727-36. PubMed ID: 15110854
    [Abstract] [Full Text] [Related]

  • 8. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D, Kuder K, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2008 Sep 15; 16(18):8729-36. PubMed ID: 18774720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I, Figlus M, Zuiderveld OP, Walczynski K.
    Arch Pharm (Weinheim); 2008 Dec 15; 341(12):762-73. PubMed ID: 19009544
    [Abstract] [Full Text] [Related]

  • 12. Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.
    Stocking EM, Aluisio L, Atack JR, Bonaventure P, Carruthers NI, Dugovic C, Everson A, Fraser I, Jiang X, Leung P, Lord B, Ly KS, Morton KL, Nepomuceno D, Shah CR, Shelton J, Soyode-Johnson A, Letavic MA.
    Bioorg Med Chem Lett; 2010 May 01; 20(9):2755-60. PubMed ID: 20382018
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series.
    Rivara M, Zuliani V, Cocconcelli G, Morini G, Comini M, Rivara S, Mor M, Bordi F, Barocelli E, Ballabeni V, Bertoni S, Plazzi PV.
    Bioorg Med Chem; 2006 Mar 01; 14(5):1413-24. PubMed ID: 16263297
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists.
    Hancock AA, Diehl MS, Faghih R, Bush EN, Krueger KM, Krishna G, Miller TR, Wilcox DM, Nguyen P, Pratt JK, Cowart MD, Esbenshade TA, Jacobson PB.
    Basic Clin Pharmacol Toxicol; 2004 Sep 01; 95(3):144-52. PubMed ID: 15447739
    [Abstract] [Full Text] [Related]

  • 17. Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.
    Labeeuw O, Levoin N, Poupardin-Olivier O, Calmels T, Ligneau X, Berrebi-Bertrand I, Robert P, Lecomte JM, Schwartz JC, Capet M.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2548-54. PubMed ID: 23535326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
    Guryn R, Staszewski M, Kopczacki P, Walczyski K.
    Med Chem; 2016 May 01; 13(1):65-76. PubMed ID: 27220560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.